Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice

PLoS One. 2013 Aug 26;8(8):e73933. doi: 10.1371/journal.pone.0073933. eCollection 2013.

Abstract

A role for microbes has been suspected in prostate cancer but difficult to confirm in human patients. We show here that a gastrointestinal (GI) tract bacterial infection is sufficient to enhance prostate intraepithelial neoplasia (PIN) and microinvasive carcinoma in a mouse model. We found that animals with a genetic predilection for dysregulation of wnt signaling, Apc (Min/+) mutant mice, were significantly susceptible to prostate cancer in an inflammation-dependent manner following infection with Helicobacter hepaticus. Further, early neoplasia observed in infected Apc (Min/+) mice was transmissible to uninfected mice by intraperitoneal injection of mesenteric lymph node (MLN) cells alone from H. hepaticus-infected mutant mice. Transmissibility of neoplasia was preventable by prior neutralization of inflammation using anti-TNF-α antibody in infected MLN donor mice. Taken together, these data confirm that systemic inflammation triggered by GI tract bacteria plays a pivotal role in tumorigenesis of the prostate gland.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Genes, APC
  • Intestines / microbiology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / microbiology*